نتایج جستجو برای: calcitonin gene

تعداد نتایج: 1144069  

2006
Madhara Udawela George Christopoulos Nanda Tilakaratne Arthur Christopoulos Anthony Albiston Patrick M. Sexton

243 Introduction 474 Discussion 1165 Non standard abbreviations: AMY, amylin receptor phenotype; CGRP, calcitonin gene-related peptide; CLR, calcitonin receptor-like receptor; CT, calcitonin; CTR, calcitonin receptor; GPCR, G protein-coupled receptor; HA, haemagglutinin epitope tag; hCT, human calcitonin; RAMP, receptor activity modifying protein; rAmy, rat amylin; sCT, salmon calcitonin; TMD, ...

Journal: :Biochemical Society transactions 1997
D R Poyner

Introduction Calcitonin-gene-related peptide (CGRP) is a 37-amino acid neuropeptide which was first identified in 1982 as a product of the calcitonin gene derived by alternative splicing [ 11. This original peptide is now referred to as a-CGRP; a second gene, unrelated to calcitonin, produces P-CGRP [2]. These two forms are closely related in both rat and man (Figure l ) , and are widely distri...

2004
JOSEPH M LAUWERYNS LIEVE VAN RANST

Calcitonin gene related peptide immunoreactivity was investigated in the rat lung. Immunoreactive material was observed in nerve fibres surrounding bronchi, bronchioli, and blood vessels, and also in neuroendocrine cells and neuroepithelial bodies. In addition, the peptide was identified by immunoelectron microscopy in dense cored vesicles of granulated cells of the neuroepithelial bodies. Thes...

Journal: :BMJ 1991
D J O'Halloran S R Bloom

Journal: :The Journal of biological chemistry 1992
L A Tverberg A F Russo

We have investigated the mechanisms underlying cell-specific glucocorticoid repression of calcitonin/calcitonin gene-related peptide (CGRP) gene expression. Treatment with the synthetic glucocorticoid dexamethasone has been shown to decrease mRNA levels in the 44-2C thyroid C cell line. Nuclear run-on assays showed that dexamethasone repressed transcription 2-3-fold in 44-2C cells. In contrast,...

Journal: :Journal of medical genetics 1988
C P Bennett J Burn G E Moore J Chambers R Williamson J Wilkinson

Supravalvular aortic stenosis (SVAS) may occur as an isolated autosomal dominant trait or as a feature of Williams syndrome. It has been suggested that a defect in calcitonin function may play a role in Williams syndrome. We have excluded calcitonin as a candidate gene for SVAS using a gene specific probe.

Journal: :iranian journal of basic medical sciences 0
zongpeng li operatiom room, linyi people’s hospital, linyi 276000, china zong gao neurosurgery department, affiliated hospital of shandong university of traditional chinese medicine, jinan 250011, china shufa li endocrinology department, linyi people’s hospital, linyi 276000, china yuanyuan zhang endocrinology department, linyi people’s hospital, linyi 276000, china lizhi xing endocrinology department, linyi people’s hospital, linyi 276000, china lanju zhang endocrinology department, linyi people’s hospital, linyi 276000, china

objective(s): as heat, pain is one of the most common clinical symptoms. generally, calcitonin (ct) is prescribed as an analgesic agent for the treatment of pain, especially for the pain caused by osteoporosis or primary and metastatic bone tumor. however, the detailed mechanism remains unknown.materials and methods: in this study, chronic constriction injury (cci) rat model was created, and ho...

Journal: :Stroke 1994
Y R Tran Dinh M Debdi J Y Couraud C Creminon J Seylaz R Sercombe

BACKGROUND AND PURPOSE Cerebral vasospasm after subarachnoid hemorrhage may result partially from the imbalance between vasodilator and vasoconstrictor factors. The vasodilator peptides substance P and calcitonin gene-related peptide contained in the trigeminovascular system are involved in the vasomotor phenomenon occurring after subarachnoid hemorrhage. The delayed arterial narrowing may refl...

2007
Nagako Akeno-Stuart Michelle Croyle Jeffrey A. Knauf Roberta Malaguarnera Donata Vitagliano Massimo Santoro Christine Stephan Konstantina Grosios Markus Wartmann Robert Cozens Giorgio Caravatti Doriano Fabbro Heidi A. Lane James A. Fagin

The RET kinase has emerged as a promising target for the therapy of medullary thyroid cancers (MTC) and of a subset of papillary thyroid cancers. NVP-AST487, a N,N ¶-diphenyl urea with an IC50 of 0.88 Mmol/L on RET kinase, inhibited RET autophosphorylation and activation of downstream effectors, and potently inhibited the growth of human thyroid cancer cell lines with activating mutations of RE...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید